Visceral fat and liver fat are independent predictors of metabolic risk factors in men

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Nguyen Duy, Thanh Binh ^a   Nichaman, Milton Z ^b   Church, Timothy S ^b   Blair, Steven N ^b   Ross, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b Cooper Institute ^*  (United States)

Author keywords

Abdominal adipose tissue; Cardiorespiratory fitness; Metabolic risk

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY DISTRIBUTION; BODY FAT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DYSLIPIDEMIA; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; LIPID STORAGE; LIVER; MALE; NORMAL HUMAN; OBESITY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS FAT; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; EXERCISE TEST; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; MALE; MIDDLE AGED; OBESITY; PHYSICAL FITNESS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038178062     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860-867, 1997.
2. Angulo P. Non-alcoholic fatty liver disease. N Eng J Med 346: 1221-1231, 2002.
3. Balke B and Ware RW. An experimental study of physical fitness in Air Force personnel. US Armed Forces Med J 10: 675-688, 1959.
4. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, and Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19: 846-850, 1995.
5. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10: 493-496, 1990.
6. Busetto L, Tregnaghi A, DeMarchi F, Segato G, Foletto M, Sergi G, Favretti F, Lise M, and Enzi G. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res 10: 408-411, 2002.
7. Crouse SF, O'Brien BC, Grandjean PW, Lowe RC, Rohack JJ, and Green JS. Effects of training and a single session of exercise on lipids and apolipoproteins in hypercholesterolemic men. J Appl Physiol 83: 2019-2028, 1997.
8. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, and Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24: 925-932, 2001.
9. Despres JP. Health consequences of visceral obesity. Ann Med 33: 534-541, 2001.
10. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10: 497-511, 1990.
11. Enevoldsen LH, Simonsen L, Stallknecht B, Galbo H, and Bülow J. In vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous abdominal adipose tissue. Am J Physiol Endocrinol Metab 281: E1110-E1114, 2001.
12. Fong DG, Nehra V, Lindor KD, and Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 32: 3-10, 2000.
13. Frayn KN. Visceral fat and insulin resistance - causative or correlative? Br J Nutr 83, Suppl 1: S71-S77, 2000.
14. Fried SK, Bunkin DA, and Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847-850, 1998.
15. Friedewald WT, Levy RI, and Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
16. Fruchart JC. Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism. Am J Cardiol 88: 24N-29N, 2001.
17. Goto T, Onuma T, Takebe K, and Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in nondiabetic Japanese subjects. Int J Obes Relat Metab Disord 19: 841-845, 1995.
18. Hood RL and Allen CE. Lipogenic enzyme activity in adipose tissue during the growth of swine with different propensities to fatten. J Nutr 103: 353-362, 1973.
19. Hsieh SD, Yoshinaga H, Muto T, and Sakurai Y. Regular physical activity and coronary risk factors in Japanese men. Circulation 97: 661-665, 1998.
20. Kelley DE, Thaete FL, Troost F, Huwe T, and Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 278: E941-E948, 2000.
21. Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751, 2001.
22. Knobler H, Schattner A, Zhornicki T, Malnick SDH, Keter D, Sokolovskaya N, Lurie Y, and Bass DD. Fatty livern - an additional and treatable feature of the insulin resistance syndrome. Q J Med 92: 73-79, 1999.
23. Kral JG, Lundholm K, Bjorntorp P, Sjostrom L, and Schersten T. Hepatic lipid metabolism in severe human obesity. Metabolism 26: 1025-1031, 1977.
24. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, and Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103, 1998.
25. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8: 146-153, 1997.
26. Maher JJ. Alcoholic steatosis and steatohepatitis. Semin Gastrointest Dis 13: 31-39, 2002.
27. Mahmood S, Taketa K, Imai K, Kajihara Y, Imai S, Yokobayashi T, Yamamoto S, Sato M, Omori H, and Manabe K. Association of fatty liver with increased ratio of visceral to subcutaneous adipose tissue in obese men. Acta Med Okayama 52: 225-231, 1998.
28. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, and Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endo Metab 84: 1513-1517, 1999.
29. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, and Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850, 2001.
30. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, and Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 5: 93-99, 1997.
31. Monzon JR, Basile R, Heneghan S, Udupi V, and Green A. Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res 10: 266-269, 2002.
32. Mourier A, Bigard AX, de Kerviler E, Roger B, Legrand H, and Guezennec CY. Combined effects of caloric restriction and branched-chain amino acid supplementation on body composition and exercise performance in elite wrestlers. Int J Sports Med 18: 47-55, 1997.
33. Muller-Wieland D, Knebel B, Avci H, Lehr S, Laudes M, Ristow M, Krone W, and Kotzka J. Insulin-regulated transcription factors: molecular link between insulin resistance and cardiovascular risk factors. Int J Obes Relat Metab Disord 25, Suppl 1: S35-S37, 2001.
34. Piekarski J, Goldberg HI, Royal SA, Axel L, and Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137: 727-729, 1980.
35. Pollock ML, Bohannon RL, Cooper KH, Ayres JJ, Ward A, White SR, and Linnerud AC. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J 92: 39-46, 1976.
36. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, Tremblay A, and Bouchard C. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826-834, 1992.
37. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, Croce LS, Paoletti S, de Bernard B, Tiribelli C, and Dalla Palma L. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27: 108-113, 1997.
38. Rich S and McLaughlin VV. Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography. Prev Med 34: 1-10, 2002.
39. Ross R, Aru J, Freeman J, Hudson R, and Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282: E657-E663, 2002.
40. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, and Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 133: 92-103, 2000.
41. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, and Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50: 425-435, 2001.
42. Thompson PD, Yurgalevitch SM, Flynn MM, Zmuda JM, Spannaus-Martin D, Saritelli A, Bausserman L, and Herbert PN. Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men. Metabolism 46: 217-223, 1997.
43. Toth MJ, Sites CK, Cefalu WT, Matthews DE, and Poehlman ET. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab 281: E113-E121, 2001.
44. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, and Tanikawa K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27: 103-107, 1997.
45. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
46. Willson TM, Lambert MH, and Kliewer SA. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 70: 341-367, 2001.